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Abstract Residues 1^9 of M(12^26) (GLPALISWIKRKRQ-
Q-NH2), the C-terminal 15-residue segment of melittin, were
substituted individually to change the hydropathicities in these
positions. Antimicrobial and hemolytic activities of these pep-
tides were determined. The results showed increased antimicro-
bial activities with increased hydrophobicities at almost all the
positions studied. The e¡ects at positions 2, 5, 8 and 9 were
signi¢cant while the e¡ects at the other positions were small.
These two groups of residues were located on the opposite faces
of the K-helix. In other words, the hydrophobicities of the two
faces were favorable, but one face (the more favorable face)
contributed more to the antimicrobial activities than the other
(the less favorable face). The hydrophobicity, not the amphipa-
thicity, seems to be crucial for antimicrobial activity. In con-
trast, the hydrophobicity of one face was favorable but the other
was unfavorable for the hemolytic activity, indicating that the
amphipathicity may be important for hemolysis. Interestingly,
the more favorable face for antimicrobial activity was located
opposite to the favorable face for hemolytic activity, indicating
the direction of the hydrophobic face for the antimicrobial ac-
tivity and direction of the amphipathicity for the hemolytic ac-
tivity were also important.
4 2003 Federation of European Biochemical Societies. Pub-
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1. Introduction
The widespread use of antibiotics has caused serious anti-
biotic resistance by pathogens. Therefore, in recent years,
much attention has been paid to search new classes of anti-
biotics that can avoid the resistance of the bacteria. The en-
dogenous antimicrobial peptides and their derivatives are at-
tractive candidates (for reviews, see [1^6]). Among the
antimicrobial peptides, short linear peptides (6 40 amino
acids) such as cecropin, magainin, melittin, etc., have at-
tracted much attention. This class of peptides shares some
common structural features, i.e. net positive charge, around
50% hydrophobic amino acid residues and a potential to form
an amphipathic K-helical structure [7^10]. These structural
features are also believed to be the cause of hemolytic activ-
ities of some antimicrobial peptides such as melittin and par-
daxin [11,12], and are similar to the structural features of
calmodulin-binding peptides [13,14] as well. Some antimicro-
bial peptides such as melittin, crabrolin, mastaparans, semi-
nalplasmin and substance P bind tightly to calmodulin. In our
previous papers [14,15], we proposed a model for the predic-
tion of the calmodulin-binding domain of the calmodulin-
binding peptides and an empirical formula to predict the bind-
ing a⁄nities. It was predicted that the calmodulin-binding
domain of melittin spans the residues 12^26. The tested a⁄n-
ities of synthetic deletion peptides of melittin, M(15^26),
M(14^26), M(13^26), M(12^26) and M(11^26), for calmodu-
lin were in good agreement with the predicted values [14,16].
We also found that the last three peptides retained antibacte-
rial activity and all the synthetic peptides had a much-reduced
hemolytic activity to human red blood cells [17]. Subbalaksh-
mi et al. also found that the C-terminal 15-residue fragment of
melittin possessed a slightly lower antimicrobial activity and
much lower hemolytic activity than melittin [18]. The struc-
ture of these peptides can be separated into two parts: N-ter-
minal hydrophobic segment (residues 1^9, for example, for
M(12^26)) and C-terminal basic residue cluster. In this paper,
using M(12^26) as the model, residues in the hydrophobic
segment (residues 1^9) were substituted individually to change
the hydropathicities of the positions. The purpose was to
study the e¡ect of the hydropathicities of individual positions
on the antimicrobial and hemolytic activities, and the di¡er-
ence between the two e¡ects as well.
2. Materials and methods
2.1. Melittin puri¢cation and peptide synthesis
Melittin was puri¢ed from bee venom [19]. Melittin analogs were
synthesized by the solid-phase peptide synthesis technique using t-bu-
tyloxycarbonyl (Boc) chemistry on a p-methylbenzhydrylamine resin
(Tianjin Nankai Hecheng Co., PR China). The Boc amino acids were
obtained from Advanced ChemTech (USA). All protected amino
acids were added with coupling mediated by dicyclohexylcarbodiimide
and 1-hydroxybenzo-triazole (ACROS). The peptides bound on the
resin were cleaved using liquid HF. The synthesized peptides were ¢rst
passed through a Sephadex G-25 (Pharmacia) column and then frac-
tionated by the use of reversed-phase high-performance liquid chro-
matography (RP-HPLC) on a C18 W-Bondpak semi-preparative col-
umn (300U19 mm, Waters Co.). The puri¢ed peptides, which were
shown to be homogeneous (s 95%) by analytical HPLC, were sub-
jected to amino acid analysis and mass spectroscopy to con¢rm their
compositions.
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2.2. RP-HPLC analyses of peptides
Peptides were analyzed by RP-HPLC on a Nova-Pak C18 column
(3.9 mmU150 mm, Waters Co.) at a £ow rate of 1 ml/min. The
sample concentration was 1 mg/ml peptide in mobile phase, which
comprised 28% acetonitrile/72% water (v/v) containing 0.1% tri£uoro-
acetic acid. The retention times (tR) of the peptides were determined
at 25‡C.
2.3. Antimicrobial activities
The antimicrobial activities of the peptides were assayed in nutrient
broth (5 g of bactonutrient broth and 5 g of NaCl per liter medium)
under aerobic conditions. Di¡erent concentrations of peptides were
added to 1 ml medium containing the inocula of the test organism
(V106 CFU) in mid-logarithmic phase of growth. Growth inhibition
was determined by measuring the OD600, following incubation for 24 h
at 37‡C. The antibacterial activity is expressed as minimal inhibitory
concentration (MIC). The microorganisms used were Gram-positive
bacteria, Staphylococcus aureus and Bacillus subtilis, and Gram-neg-
ative bacterium Escherichia coli.
2.4. Hemolytic activity
The hemolytic activities of the peptides were tested against human
erythrocytes. The erythrocytes were suspended in phosphate-bu¡ered
saline (PBS). Peptides dissolved in PBS were then added to 500 Wl of a
solution of the stock erythrocytes in PBS to reach a ¢nal volume of
1000 Wl (¢nal erythrocyte concentration, 2.5% v/v). The resulting sus-
pension was incubated for 60 min at 37‡C with gentle mixing. The
samples were then centrifuged and the absorbance of the supernatants
was measured at 414 nm. Controls for zero hemolysis (blank) and
100% hemolysis consisted of erythrocyte suspended in PBS and 1%
Triton, respectively. The hemolytic activity is expressed as concentra-
tions required for 100% (HC100), 50% (HC50), or 10% (HC10) lysis of
human erythrocytes, respectively.
2.5. Circular dichroism (CD) spectroscopy
The CD spectra were measured with a JASCO-J-715 spectra polar-
imeter under nitrogen £ush in 1-cm path length cells at 25‡C. The
spectra were recorded between 250 and 200 nm and the average of
three recordings was taken. The calibration was carried out with
d-camphorsulfonic acid. The peptides were scanned at concentrations
of 1.5U1035^2.0U1035 M. The percentage of K-helical structure was
calculated as follows: K-helix (%)= ([a]2223[a]0222)/[a]
100
222, where [a]222 is
the experimentally observed absolute mean residue ellipticity at 222
nm. Values for [a]0222 and [a]
100
222, corresponding to 0 and 100% helix
content at 222 nm, were estimated to be 32000 and 328 400 degrees
cm2/dmol, respectively [20].
3. Results
3.1. Design of peptides
In our previous papers it was shown that the C-terminal
segment, M(12^26), of melittin retained antibacterial activity
but had a much reduced hemolytic activity to human red
blood cells [17]. M(12^26) consists of an N-terminal hydro-
phobic segment (residues 1^9) and a cluster of basic residues
(Lys10-Arg11-Lys12-Arg13) in the C-terminus. In order to study
the e¡ect of the hydrophobicity of individual residues of the
hydrophobic segment on the antimicrobial and hemolytic ac-
tivities, a series of analogs with modi¢ed hydrophobicities
were designed, as shown in Table 1. The hydrophobic residues
Leu2, Leu5, Ile6 and Ile9 in M(12^26) were individually re-
placed by a hydrophilic amino acid, Ser, in four parallel syn-
theses. Similarly, the hydrophilic residues Gly1, Ala4 and Ser7
were individually replaced by a hydrophobic amino acid, Leu,
in three other parallel syntheses. The e¡ect of the hydropa-
thicity at each of these positions was studied by comparing
each of the substituted peptides with the model peptide,
M(12^26). Trp at position 8 is a sole aromatic amino acid
residue in the model peptide. It was reported that Trp might
play a role for the antimicrobial and hemolytic activities in
antimicrobial peptides [21,22]. In order to eliminate the in£u-
ence of aromatic residue on the antimicrobial and hemolytic
activities in the comparison, two peptides were synthesized. In
one of the peptides Trp8 was replaced by a hydrophobic ami-
no acid, Leu, and in the other by a hydrophilic one, Ser. The
in£uence of the hydropathicity at this position was compared
using the two substituted peptides. Pro is the only amino acid
with the K-amino group in a ring structure (secondary amine
group) in the 20 natural amino acids, which is an N-terminal
helical boundary residue but a strong helical breaker [23].
Okada et al. [24] reported that when melittin was bound to
phosphatidylcholine vesicles the C-terminal Leu13-Lys21 (cor-
responding to Leu2-Lys10 of the M(12^26)) segment had an
K-helical conformation. Pro14 (corresponding to Pro3 of
M(12^26)) was thus located in the interior of the K-helical
conformation. When Pro occurs in the interior of an K-helix
it breaks at least two adjacent H bonds and its ring pushes the
proceeding turn of backbone away by an aﬁngstrom [25]. To
eliminate this e¡ect, similar to the substitutions at position 8,
Pro3 was replaced with a hydrophobic amino acid, Leu, and
by a hydrophilic one, Ser, respectively, and the in£uence of
the hydropathicity at this position was compared using the
two substituted peptides.
3.2. Antimicrobial and hemolytic activities of the peptides
The MICs of melittin and its analogs against Gram-positive
(S. aureus and B. subtilis) and Gram-negative species (E. coli)
were determined by serial dilution microbroth, as shown in
Table 2. Melittin was used as the control. All the peptides had
much lower MICs against the Gram-positive bacteria than
Table 1
Sequences, calculated hydrophobicities, hydrophobic moments, and retention times on RP-HPLC of melittin and its analogs
Peptide Sequence Hma WHa tR (min)
Melittin GIGAVLKVLTTGLPALISWIKRKRQQ-NH2 30.086 0.22 s 80
Mel(12^26) GLPALISWIKRKRQQ-NH2 30.28 0.20 20.32
Mel(12^26, L1) LLPALISWIKRKRQQ-NH2 30.26 0.21 20.72
Mel(12^26, S2) GSPALISWIKRKRQQ-NH2 30.33 0.16 4.6
Mel(12^26, L3) GLLALISWIKRKRQQ-NH2 30.24 0.17 45
Mel(12^26, S3) GLSALISWIKRKRQQ-NH2 30.29 0.21 ^
Mel(12^26, L4) GLPLLISWIKRKRQQ-NH2 30.30 0.19 28.59
Mel(12^26, S5) GLPASISWIKRKRQQ-NH2 30.33 0.15 3.61
Mel(12^26, S6) GLPALSSWIKRKRQQ-NH2 30.35 0.20 5.53
Mel(12^26, L7) GLPALILWIKRKRQQ-NH2 30.23 0.15 18.49
Mel(12^26, L8) GLPALISLIKRKRQQ-NH2 30.27 0.20 13.1
Mel(12^26, S8) GLPALISSIKRKRQQ-NH2 30.32 0.20 5.10
Mel(12^26, S9) GLPALISWSKRKRQQ-NH2 30.35 0.14 5.17
aMean hydrophobicities (Hm) and hydrophobic moments (WH) were calculated using consensus values of hydrophobicity scale [26].
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against the Gram-negative one. Some of the MICs against
E. coli exceeded the concentration ranges tested. The antimi-
crobial activity analysis was thus limited to the antimicrobial
activity against the Gram-positive species below. It was found
from Table 2 that the antimicrobial activity increased with
increasing hydrophobicity at any individual position studied,
with the exception of positions 3 and 7 against B. subtilis.
Hemolytic activities of the peptides to human erythrocytes
were determined and listed in Table 2. Most of the synthetic
peptides had very low hemolytic activities. The concentrations
required for 100% lysis (HC100) or 50% lysis (HC50) exceeded
the concentration ranges tested for most of the peptides. In
order to quantitatively compare the hemolytic activities of the
peptides, the concentrations required for 10% lysis (HC10)
were determined.
3.3. E¡ect of the hydropathicities of the individual residues on
the antimicrobial and hemolytic activities
The Eisenberg consensus scale [26] was used as the measure
of hydropathicity of single amino acid residues. The e¡ect of
the hydropathicity of each individual residue on the antimi-
crobial activity was measured by the antimicrobial activity
change (vMIC) divided by the Eisenberg consensus hydropa-
thicity change (vH) between the peptides with hydrophobic
and hydrophilic residues at the position. Similarly, the e¡ect
of the hydropathicity of each individual residue on the hemo-
lytic activity was measured by the hemolytic activity change
(vHC10) divided by the hydropathicity change (vH). Fig. 1
shows the plot of vMIC/vH against the residue number. It
is clear that the antimicrobial activity increased with increas-
ing hydrophobicity at any of the positions, except for posi-
tions 3 and 7 against B. subtilis. However, the dependences of
the antimicrobial activities on the hydrophobicities at di¡erent
positions were di¡erent. The e¡ects at positions 2, 5, 8 and 9
were signi¢cant while the e¡ects at positions 1, 3, 4, 6 and 7
were small. Compared with the helical-wheel projection (Fig.
2), these two groups of residues were located on opposite
sides. Fig. 2 was made based on the report of Okada et al.
[24] that ¢ve C-terminal residues (Arg22-Gln26, corresponding
to Arg11-Gln15 of M(12^26)) did not show a unique confor-
mation when melittin was bound to phosphatidylcholine
vesicles.
Fig. 3 is the plot of vHC10/vH as a function of residue
number. In contrast to the antimicrobial activities, the hemo-
lytic activities increased with increasing hydrophobicities at
some positions, such as residues 1, 4, 7, 8 and 9, and de-
creased at other positions, such as residues 2, 5 and 6. The
former group of residues (with the exception of residue 9) and
the latter group are located on opposite sides of the K-helix.
The unusual behavior of residue 9 probably correlated with its
direct link to the basic residue cluster. Little e¡ect was ob-
served at position 3. Interestingly, the face (left-hand side in
Fig. 2) whose hydrophobicity was more favorable for the
antimicrobial activity and the face (right-hand side in Fig.
2) whose hydrophobicity was favorable for the hemolytic ac-
tivity were located on opposite sides.
Table 2
Antimicrobial and hemolytic activities of melittin and its analogs
Peptide MIC (Wg/ml) Hemolytic activity (Wg/ml)
S. aureus B. subtilis E. coli HC100 HC50 HC10
Melittin 0.72 0.18 11.4 10 5 1.78
Mel(12^26) 5.6 5.6 88.9 ^ ^ 4 500
Mel(12^26, L1) 1.1 2.2 70.8 ^ 1 450 192
Mel(12^26, S2) 90 67.5 s 270 ^ ^ 1 588
Mel(12^26, L3) 1.2 2.2 70.8 ^ 120 35.2
Mel(12^26, S3) 3.1 1.6 6.25 ^ 403 44.0
Mel(12^26, L4) 1.3 2.4 76.7 ^ 1 300 203
Mel(12^26, S5) 250 31.2 s 250 ^ ^ 3 840
Mel(12^26, S6) 14.6 39 311 ^ ^ 650
Mel(12^26, L7) 1.4 0.64 81.7 ^ 620 15.4
Mel(12^26, L8) 13.5 10.0 161 ^ ^ 9 350a
Mel(12^26, S8) 38.2 76.4 s 305 ^ ^ 13 800a
Mel(12^26, S9) 94.2 70.8 s 94.4 ^ ^ 6140
aData were obtained by extrapolating to higher concentrations than the testing range.
Fig. 1. The e¡ect of hydrophobicity of each individual position on
the antimicrobial activity. Fig. 2. Helical wheel projection of M(12^26).
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3.4. K-Helical structures determined by CD
The CD results showed that melittin and its analogs
adopted random coil structures (data not shown) in 10 mM
Tris^HCl bu¡er. The K-helical content of melittin increased
from 10% in salt-free bu¡er to 47% in 2 M NaCl, which was
in accordance with the results reported by Goto and Hagihara
and was believed to be caused by melittin aggregation [27],
while no remarkable increase in the content of K-helical struc-
ture for all the synthetic peptides was observed (data not
shown), indicating the synthetic peptides could not form ag-
gregates in this condition. The K-helical content of the syn-
thetic peptides and melittin increased markedly in 30 mM
SDS and 10% HFIP (27^82%), respectively, which mimic
the membrane environment, indicating the peptides have an
inherent helicity. No obvious correlations between the bioac-
tivities and K-helical structures were observed.
3.5. Correlations of antimicrobial activities with
hydrophobicities of the peptides
The calculated hydrophobicities, hydrophobic moments and
retention times of melittin and its analogs are listed in Table
1. Plots of Hm against tR and WH against tR (not shown),
respectively, indicated that the calculated hydrophobicities
and the retention times were linearly correlated, while no cor-
relation between the hydrophobic moments and the retention
times was found. Analyzing the data we found that both the
calculated hydrophobicities and the retention times correlated
well with the antimicrobial activities, and the retention times
had a better correlation than the calculated hydrophobicities.
Thus the retention times are good measurements of the hydro-
phobicities of the peptides. Figs. 4 and 5 show the correlations
between the retention times and the antimicrobial activities.
The data reveal no correlation of the hydrophobic moments
to the antimicrobial activities, and no correlation of the cal-
culated hydrophobicities, hydrophobic moments and retention
times, respectively, to the hemolytic activities as well.
4. Discussion
One of the main aims of the current study on the antimi-
crobial peptides is to obtain the maximum possible antimicro-
bial activity accompanied by the minimum toxicity toward the
host. To attain this purpose, investigation of the structure^
activity relationships or the mechanisms of antimicrobial ac-
tivity and the toxicity toward the host (usually hemolysis) may
be most important. The selectivity was believed to be caused
by the di¡erent compositions of the membranes of bacteria
and mammalian cells. Our results showed that the hydropho-
bicity at all directions of the K-helix of this series of peptides
contributed to the antimicrobial activity, but the hydropho-
bicity on one face was more favorable than that on the other
(see Figs. 1 and 2). These results indicated that the peptides
might adopt K-helical structures upon binding to the mem-
branes of bacteria. The direction of the faces probably de-
pended on the electrostatic interactions. The hydrophobicity
and the direction of the hydrophobic face, not the amphipa-
thicity, seem to be crucial for antimicrobial activity. In con-
trast, amphipathicity was important for hemolysis (see Figs. 2
and 3). Interestingly, we found that the face of the K-helix
whose hydrophobicity was favorable for hemolysis was oppo-
site to the face whose hydrophobicity was more favorable for
antimicrobial activity, indicating that the direction of the am-
phipathicity was also important for hemolysis. The ¢rst step
of the action of peptides to the membranes seems to be elec-
trostatic interactions between the positively charged peptides
and negatively charged phospholipid membranes. Then the
orientation of the left face (see Fig. 2) probably exactly faces
the hydrophobic fatty acyl chains in the membrane of bacte-
ria. The right face might interact with a less hydrophobic
environment, e.g. membrane proteins. In the binding of the
peptides to the membrane of erythrocytes, the orientation of
the right face probably exactly faces the hydrophobic fatty
acyl chains.
Fig. 3. The e¡ect of hydrophobicity of each individual position on
the hemolytic activity.
Fig. 4. Correlation between the antimicrobial activity against S. au-
reus and the retention time on RP-HPLC.
Fig. 5. Correlation between the antimicrobial activity against B. sub-
tilis and the retention time on RP-HPLC.
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It has been proposed that electrostatic interactions between
the positively charged peptides and the negatively charged
phospholipid membranes seem to play an important role in
initial interactions, but biological activity appears to be driven
by the hydrophobic interactions between the non-polar amino
acids and the hydrophobic core of the lipid bilayer [1]. As
both faces of the K-helix contributed to the hydrophobic in-
teraction in the binding of the peptide to the membranes of
bacteria, while only one face contributed to the binding of the
peptide to the membranes of erythrocytes, the former binding
was probably stronger than the latter. Therefore membranes
of bacteria might be a much stronger promoter of K-helical
structures than those of erythrocytes. This is supported by the
results of Shai and coworkers [28^32], who designed a series
of diastereomers of natural antimicrobial or model amphi-
pathic peptides. The diastereomers were composed of both
L- and D-amino acids which probably disrupt the formation
of a helical structure. The CD spectra indicated that the dia-
stereomers tested had little or no speci¢c secondary structure
in tri£uoroethanol, a solvent strongly promoting K-helical
structure [28^30]. However, ATR-FTIR data showed that
the diastereomers adopted distorted or 310-helices when they
were bound to phosphatidyletyanolamine (PE)/ phosphatidyl-
glycerol (PG) (7/3, w/w) phospholipid, which mimics E. coli
membranes [31,32]. These diastereomers retained antimicro-
bial activities and had much-reduced hemolytic activities.
It has been reported that retention times of peptides on RP-
HPLC correlated with their hydrophobicities for some groups
of peptides [33^35] or with their amphipathicities, which have
often been quantitatively measured by hydrophobic moments,
for others [36,37]. Our results belong to the former case, i.e.
the antimicrobial activity of the peptides correlated well with
their hydrophobicities. However, no correlation between the
hemolytic activities and the hydrophobicities or the hydro-
phobic moments existed. These results are not surprising, as
the hydrophobicities of all the directions of the K-helical struc-
ture were favorable for the antimicrobial activities, although
one face was more favorable than the other, while not only
the amphipathicities but their directions in£uenced the hemo-
lytic activities.
5. Conclusion
By comparing the e¡ect of the hydrophobicity at each po-
sition of residues 1^9 of M(12^26) on the antimicrobial and
hemolytic activities, three main conclusions can be drawn:
(1) The hydrophobicities in all the directions of the K-helical
wheel projection of this series of peptides was favorable for
the antimicrobial activity, but one face of the K-helix had a
greater e¡ect than the other. Thus the peptides might adopt
K-helical structures upon binding to the membranes of bacte-
ria. (2) The hydrophobicity on one face was favorable for the
hemolytic activity, but unfavorable on the other. Thus amphi-
pathicity might be important for hemolysis. (3) The direction
of the face whose hydrophobicity was more favorable for the
antimicrobial activity was opposite to that of the face whose
hydrophobicity was favorable for hemolytic activity. The di-
rections might depend on the electrostatic interactions.
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